123 Optimising MRCP Referrals in Low-to-Moderate Risk Patients for Common Bile Duct Stones: A Two-Cycle QI Project
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.075 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von R Vaitha und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Appropriate Magnetic Resonance Cholangiopancreatography (MRCP) use in low-to-moderate risk gallstone patients with suspected common bile duct stones (CBDS) lacks clear protocols, leading to variable clinician discretion, inefficiency, and delays. This quality improvement project (QIP) aimed to enhance MRCP referral quality using iRefer clinical decision support (CDS) while maintaining diagnostic and clinical safety.
Method
A ‘Plan-Do-Study-Act’ model compared retrospective data (Jan-Dec 2024, Cycle 1) with prospective post-iRefer implementation data (June–July 2025, Cycle 2) at a tertiary centre. Low-moderate risk patients were defined per Sunflower Study criteria. Outcomes: referral documentation completeness, MRCP yield, median time to MRCP, laparoscopic cholecystectomy rate and timing, ERCP rate, and complications.
Results
Cycle 1: n=72 patients. Explicit indication documentation: 37%, biochemistry documentation: 71%, prior imaging documentation: 63%. MRCP yield: 6.9%. Median MRCP wait was 12 days; median time to lap chole was 15 days (range 1–54). All patients underwent laparoscopic cholecystectomy with a 3% complication rate. Cycle 2: n=59 patients. Explicit indication documentation: 81% (+44%), biochemistry documentation: 88% (+17%), prior imaging documentation: 80% (+17%). MRCP yield remained stable at 7%. Median MRCP wait decreased to 8 days (33%), and median laparoscopic cholecystectomy time to 11 days (range 1–38, 27% reduction). Surgery rate: 90%. ERCP and complication rate remained unchanged.
Conclusion
Integrating CDS via iRefer significantly improves MRCP referral clarity, optimises diagnostic pathways, and maintains safe surgical outcomes. While large trials such as the SUNFLOWER study define imaging necessity in this population, this QI study shows how system-level interventions enhance multidisciplinary care to improve clinical care outcomes.
Zitieren
APA
Vaitha, R., Porter, D., Gould, T., Chandwani, M., Bond-Smith, G., & Pearce, P. (2026). 123 Optimising MRCP Referrals in Low-to-Moderate Risk Patients for Common Bile Duct Stones: A Two-Cycle QI Project. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.075
Vancouver
Vaitha R, Porter D, Gould T, Chandwani M, Bond-Smith G, Pearce P. 123 Optimising MRCP Referrals in Low-to-Moderate Risk Patients for Common Bile Duct Stones: A Two-Cycle QI Project. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.075
BibTeX
@article{Vaitha2026,
author = {Vaitha, R and Porter, D and Gould, T and Chandwani, M and Bond-Smith, G and Pearce, P},
title = {123 Optimising MRCP Referrals in Low-to-Moderate Risk Patients for Common Bile Duct Stones: A Two-Cycle QI Project},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.075}
}
EUVIMED